High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission.
about
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: impact on stem cell harvesting and engraftment.Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trialsBenefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable diseaseHigh-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma.Retrospective analysis of 264 multiple myeloma patients.Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma.Initial treatment of transplant-eligible patients in multiple myeloma.Novel drugs for the treatment of multiple myelomaBortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country.Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.Serum M-spike and transplant outcome in patients with multiple myeloma.
P2860
Q30301228-AD178159-ED85-419C-AFF2-7318573BB5D7Q33376918-16189DEF-6455-4FBC-A276-7787B62F77D4Q34172071-1589C19C-4348-426C-9ED1-8412595AE601Q35944707-6FBDFB44-FB0E-484F-BBF7-0ECCD25F8EF6Q36407446-6DA2178F-D11D-4F4D-B84C-B8B7BFE96505Q36573022-88115D30-9D48-43EC-BD1B-F2FDE9B8FD6DQ36611531-C6AED452-5722-492B-B063-18DC9230CA1FQ37162610-CF7AC97D-4C27-4447-A43E-CC47F6D351D4Q38176061-81B296C8-E00E-415D-8861-FB00FC20E05BQ42793018-66CA5DBE-C138-478E-B3FD-A5365425EFADQ43225847-4F33CBFE-87DE-4695-BB7A-130E431FB8D4Q53206127-79D3E4BA-E05B-4B5F-97A9-8583E2C22BFEQ53259579-32CBC2D7-E611-46E6-9CD0-1463DC4C2943Q53554571-EED6DA59-0923-478C-8089-DD5580661134
P2860
High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
High-dose therapy/autologous s ...... dictors of complete remission.
@en
High-dose therapy/autologous s ...... dictors of complete remission.
@nl
type
label
High-dose therapy/autologous s ...... dictors of complete remission.
@en
High-dose therapy/autologous s ...... dictors of complete remission.
@nl
prefLabel
High-dose therapy/autologous s ...... dictors of complete remission.
@en
High-dose therapy/autologous s ...... dictors of complete remission.
@nl
P2093
P2860
P356
P1476
High-dose therapy/autologous s ...... dictors of complete remission.
@en
P2093
Carreras E
Fernández-Avilés F
Martinez C
Montserrat E
P2860
P2888
P356
10.1038/SJ.BMT.1704313
P407
P577
2004-01-01T00:00:00Z